Limiting antibiotic resistance in acne treatment

References

• Thiboutot D, Gollnick H, Bettoli V et al.; Global Alliance to Improve Outcomes in Acne. New insights into the management of acne: an update from the global alliance to improve outcomes in acne group. J. Am. Acad. Dermatol. 60(Suppl. 5), 1–50 (2009).
   PubMed Web of Science ®Google Scholar
• Stern RS. Medication and medical service utilization for acne 1995–1998. J. Am. Acad. Dermatol. 43(6), 1042–1048 (2000).
   PubMedGoogle Scholar
• Leyden JJ, Del Rosso JQ, Webster GF. Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance. Cutis. 79(Suppl. 6), 9–25 (2007).
   PubMed Web of Science ®Google Scholar
• Cooper AJ. Systematic review of Propionibacterium acnes resistance to systemic antibiotics. Med. J. Aust. 169(5), 259–261 (1998).
   PubMed Web of Science ®Google Scholar
• Leyden JJ, McGinley KJ, Cavalieri S, Webster GF, Mills OH, Kligman AM. Propionibacterium acnes resistance to antibiotics in acne patients. J. Am. Acad. Dermatol. 8(1), 41–45 (1983).
   PubMed Web of Science ®Google Scholar
• Eady EA, Cove JH, Holland KT, Cunliffe WJ. Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure. Br. J. Dermatol. 121(1), 51–57 (1989).
   PubMed Web of Science ®Google Scholar
• Leyden JJ, Preston N, Osborn C, Gottschalk RW. In-vivo effectiveness of adapalene 0.1%/benzoyl peroxide 2.5% gel on antibiotic-sensitive and resistant Propionibacterium acnes. J. Clin. Aesthet. Dermatol. 4(5), 22–26 (2011).
   PubMedGoogle Scholar
• Cunliffe WJ, Holland KT, Bojar R, Levy SF. A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris. Clin. Ther. 24(7), 1117–1133 (2002).
   PubMed Web of Science ®Google Scholar
• Simonart T, Dramaix M. Treatment of acne with topical antibiotics: lessons from clinical studies. Br. J. Dermatol. 153(2), 395–403 (2005).
   PubMed Web of Science ®Google Scholar
• Harkaway KS, McGinley KJ, Foglia AN et al. Antibiotic resistance patterns in coagulase-negative staphylococci after treatment with topical erythromycin, benzoyl peroxide, and combination therapy. Br. J. Dermatol. 126(6), 586–590 (1992).
   PubMedGoogle Scholar
• Levy RM, Huang EY, Roling D, Leyden JJ, Margolis DJ. Effect of antibiotics on the oropharyngeal flora in patients with acne. Arch. Dermatol. 139(4), 467–471 (2003).
   PubMedGoogle Scholar
• Vowels BR, Feingold DS, Sloughfy C et al. Effects of topical erythromycin on ecology of aerobic cutaneous bacterial flora. Antimicrob. Agents Chemother. 40(11), 2598–2604 (1996).
   PubMedGoogle Scholar
• Mills O Jr, Thornsberry C, Cardin CW, Smiles KA, Leyden JJ. Bacterial resistance and therapeutic outcome following three months of topical acne therapy with 2% erythromycin gel versus its vehicle. Acta Derm. Venereol. 82(4), 260–265 (2002).
   PubMed Web of Science ®Google Scholar
• Naidoo J, Noble WC. Skin as a source of transferable antibiotic resistance in coagulase-negative staphylococci. Zentralblatt Bakt. 16, 225–234 (1987).
   Google Scholar
• Eady EA, Jones CE, Gardner KJ, Taylor JP, Cove JH, Cunliffe WJ. Tetracycline-resistant propionibacteria from acne patients are cross-resistant to doxycycline, but sensitive to minocycline. Br. J. Dermatol. 128(5), 556–560 (1993).
   PubMed Web of Science ®Google Scholar
• Thiboutot DM, Shalita AR, Yamauchi PS et al. Adapalene gel, 0.1%, as maintenance therapy for acne vulgaris: a randomized, controlled, investigator-blind follow-up of a recent combination study. Arch. Dermatol. 142(5), 597–602 (2006).
   PubMed Web of Science ®Google Scholar
• Eady EA, Farmery MR, Ross JI, Cove JH, Cunliffe WJ. Effects of benzoyl peroxide and erythromycin alone and in combination against antibiotic-sensitive and -resistant skin bacteria from acne patients. Br. J. Dermatol. 131(3), 331–336 (1994).
   PubMed Web of Science ®Google Scholar
• Eady EA, Bojar RA, Jones CE, Cove JH, Holland KT, Cunliffe WJ. The effects of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin-resistant propionibacteria. Br. J. Dermatol. 134(1), 107–113 (1996).
   PubMed Web of Science ®Google Scholar
• Skidmore R, Kovach R, Walker C et al. Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne. Arch. Dermatol. 139(4), 459–464 (2003).
   PubMed Web of Science ®Google Scholar
• Toossi P, Farshchian M, Malekzad F, Mohtasham N, Kimyai-Asadi A. Subantimicrobial-dose doxycycline in the treatment of moderate facial acne. J. Drugs Dermatol. 7(12), 1149–1152 (2008).
   PubMedGoogle Scholar